Real-world data from INFORM study demonstrate increased risk of severe COVID-19
outcomes among all individuals with immunocompromising conditions
 and highlight need for additional protection.

FluMist Quadrivalent data support the potential for a self-administered influenza vaccine to expand access to an important tool for prevention.